Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.
Wittawatmongkol O, Bunjoungmanee P, Kosalaraksa P, Laoprasopwattana K, Boonsathorn S, Chantasrisawad N, Sudjaritruk T, Niyomnaitham S, Senawong S, Srisutthisamphan K, Quan Toh Z, Rungmaitree S, Nanthapisal S, Phanthanawiboon S, Khantee P, Techasaensiri C, Hirankarn N, Pangprasertkul S, Chokephaibulkit K. Wittawatmongkol O, et al. Among authors: nanthapisal s. Vaccine. 2023 Sep 15;41(40):5834-5840. doi: 10.1016/j.vaccine.2023.08.021. Epub 2023 Aug 14. Vaccine. 2023. PMID: 37586956 Free article. Clinical Trial.
Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.
Niyomnaitham S, Jongkaewwattana A, Meesing A, Pinpathomrat N, Nanthapisal S, Hirankarn N, Siwamogsatham S, Kirdlarp S, Chaiwarith R, Lawpoolsri S, Phanthanawiboon S, Thitithanyanont A, Hansasuta P, Chaiyaroj S, Pitisuttithum P. Niyomnaitham S, et al. Among authors: nanthapisal s. Int J Infect Dis. 2023 Apr;129:19-31. doi: 10.1016/j.ijid.2023.01.022. Epub 2023 Jan 20. Int J Infect Dis. 2023. PMID: 36682680 Free PMC article. Clinical Trial.
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial.
Muangnoicharoen S, Wiangcharoen R, Nanthapisal S, Kamolratakul S, Lawpoolsri S, Jongkaewwattana A, Thitithanyanont A, Luvira V, Chinwangso P, Thanthamnu N, Chantratita N, Lim JK, Anh Wartel T, Excler JL, Ryser MF, Leong C, Mak TK, Pitisuttithum P. Muangnoicharoen S, et al. Among authors: nanthapisal s. Vaccine. 2023 Jul 19;41(32):4648-4657. doi: 10.1016/j.vaccine.2023.06.043. Epub 2023 Jun 15. Vaccine. 2023. PMID: 37344265 Free PMC article. Clinical Trial.
Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?
Sritipsukho P, Khawcharoenporn T, Siribumrungwong B, Damronglerd P, Suwantarat N, Satdhabudha A, Chaiyakulsil C, Sinlapamongkolkul P, Tangsathapornpong A, Bunjoungmanee P, Nanthapisal S, Tanprasertkul C, Sritipsukho N, Mingmalairak C, Apisarnthanarak A, Tantiyavarong P. Sritipsukho P, et al. Among authors: nanthapisal s. Emerg Microbes Infect. 2023 Dec;12(1):2174779. doi: 10.1080/22221751.2023.2174779. Emerg Microbes Infect. 2023. PMID: 36715323 Free PMC article.
Effects of a new amino acid, rice glucose polymer-based, and commercial amino acid-based formulas on growth and protein status of infants with cow's milk protein allergy.
Densupsoontorn N, Jirapinyo P, Rukprayoon H, Kunnangja S, Chotipanang K, Pacharn P, Thaweekul P, Nanthapisal S. Densupsoontorn N, et al. Among authors: nanthapisal s. Asian Pac J Allergy Immunol. 2023 Jul 16. doi: 10.12932/AP-270123-1536. Online ahead of print. Asian Pac J Allergy Immunol. 2023. PMID: 37466967 Free article.
Diagnostic accuracy of atopy patch test in children with cow's milk allergy.
Kulalert P, Pongcharoen P, Sritipsukho P, Intraakhao S, Piriyanon P, Thaweekul P, Nanthapisal S, Poachanukoon O. Kulalert P, et al. Among authors: nanthapisal s. Clin Mol Allergy. 2023 Apr 7;21(1):2. doi: 10.1186/s12948-023-00183-6. Clin Mol Allergy. 2023. PMID: 37029394 Free PMC article.
Inhibitory effect of Zingiber cassumunar Roxb. (Phlai) on nasal cytokine productions and eosinophilic recruitment in patients with allergic rhinitis.
Achararit N, Tharabenjasin P, Kulalert P, Sritipsukho P, Nanthapisal S, Pabalan N, Krishnamra N, Suntornsaratoon P, Poachanukoon O. Achararit N, et al. Among authors: nanthapisal s. Asian Pac J Allergy Immunol. 2024 Mar;42(1):14-23. doi: 10.12932/AP-241022-1486. Asian Pac J Allergy Immunol. 2024. PMID: 37302093 Free article. Clinical Trial.
Heterologous Ad26.COV2.S booster after primary BBIBP-CorV vaccination against SARS-CoV-2 infection: 1-year follow-up of a phase 1/2 open-label trial.
Muangnoicharoen S, Wiangcharoen R, Lawpoolsri S, Nanthapisal S, Jongkaewwattana A, Duangdee C, Kamolratanakul S, Luvira V, Thanthamnu N, Chantratita N, Thitithanyanont A, Anh Wartel T, Excler JL, Ryser MF, Leong C, Mak TK, Pitisuttithum P. Muangnoicharoen S, et al. Among authors: nanthapisal s. Vaccine. 2024 May 13:S0264-410X(24)00556-5. doi: 10.1016/j.vaccine.2024.05.010. Online ahead of print. Vaccine. 2024. PMID: 38744598
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.
Tangsathapornpong A, Nanthapisal S, Pontan K, Bunjoungmanee P, Neamkul Y, Boonyarangkul A, Wanpen S, Fukpho W, Jitpokasem S, Tharabenjasin P, Jaru-Ampornpan P. Tangsathapornpong A, et al. Among authors: nanthapisal s. Vaccines (Basel). 2023 Feb 27;11(3):553. doi: 10.3390/vaccines11030553. Vaccines (Basel). 2023. PMID: 36992137 Free PMC article.
35 results